Development and pre-clinical analysis of a Plasmodium falciparum Merozoite Surface Protein-142 malaria vaccine
- 15 April 2003
- journal article
- Published by Elsevier in Molecular and Biochemical Parasitology
- Vol. 128 (2), 195-204
- https://doi.org/10.1016/s0166-6851(03)00077-x
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Inhibitory and blocking monoclonal antibody epitopes on merozoite surface protein 1 of the malaria parasite Plasmodium falciparum11Edited by J. A. WellsJournal of Molecular Biology, 2001
- Solution structure of an EGF module pair from the Plasmodium falciparum merozoite surface protein 1Journal of Molecular Biology, 1999
- Antibodies that Inhibit Malaria Merozoite Surface Protein–1 Processing and Erythrocyte Invasion Are Blocked by Naturally Acquired Human AntibodiesThe Journal of Experimental Medicine, 1997
- Clinical Immunity to Plasmodium falciparum Malaria Is Associated with Serum Antibodies to the 19-kDa C-Terminal Fragment of the Merozoite Surface Antigen, PfMSP-lThe Journal of Infectious Diseases, 1996
- Expression of the 19-kilodalton carboxy-terminal fragment of the Plasmodium falciparum merozoite surface protein-1 in Escherichia coli as a correctly folded proteinMolecular and Biochemical Parasitology, 1994
- Proteins on the surface of the malaria parasite and cell invasionParasitology, 1994
- The major merozoite surface protein as a malaria vaccine targetParasitology Today, 1993
- A single fragment of a malaria merozoite surface protein remains on the parasite during red cell invasion and is the target of invasion-inhibiting antibodies.The Journal of Experimental Medicine, 1990
- Antigens of the erythrocytic stages of the human malaria parasite Plasmodium falciparum detected by monoclonal antibodiesMolecular and Biochemical Parasitology, 1983
- Gamma-Globulin and Acquired Immunity to Human MalariaNature, 1961